Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCX 4016 for Walking Distance in PAD
NCT01256775Phase 2Completed
- Sponsor
- Nicox SA
- Start
- Sep 2003
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitroaspirin in Peripheral Arterial Disease (PAD), sponsored by Nicox SA. Started Sep 2003; status: completed.
02
Drugs
nitroaspirin
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01256775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256775.